The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation

American Journal of Neuroradiology

Volumn 19, Issue 4, 1998, Pages 601-608

  Zimmer, Wendy E ^a   Hourihane, J Maurice ^b   Wang, Henry Z ^a   Schriber, Jeffery R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HLA ANTIGEN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD BRAIN BARRIER; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; SCHOOL CHILD;

ADULT; BONE MARROW TRANSPLANTATION; BRAIN; CHILD; CYCLOSPORINE; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEIZURES; TOMOGRAPHY, X-RAY COMPUTED; VISION DISORDERS;

EID: 0032231717     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Vogelsang G. Pharmacology and use of immunosuppressive agents after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Boston, Mass: Blackwell Scientific; 1994
2. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-1738
3. Berden JHM, Hoitsma AJ, Merx JL, Keyser A. Severe central nervous system toxicity associated with cyclosporine. Lancet 1985; 1:219-220
4. Truwit CL, Denaro CP, Lake JR, DeMarco TD. MR imaging of reversible cyclosporine-A induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659
5. Wilson, SE, de Groen PC, Aksamit AJ, Wiesner RH, Garrity JA, Krom RAF. Cyclosporine A-induced reversible cortical blindness. J Clin Neuroopthalmol 1988;51:215-220
6. Hughes RL. Cyclosporine-related central nervous system toxicity in cardiac transplantation. N Engl J Med 1990;323:420-421
7. Gottrand F, Largilliere C, Farriaux JP. Cyclopsorine neurotoxicity. N Engl J Med 1991;324:1744-1745
8. Bhatt BD, Meriano FV, Buchwald D. Cyclosporine associated central nervous system toxicity. N Engl J Med 1988;318:788-789
9. Tollemar J, Ringden O, Ericzon BG, Tyden G. Cyclosporine associated central nervous system toxicity. N Engl J Med 1988;318:788-789
10. Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporine A toxicity. Neurology 1987;37:1072-1076
11. Scheinman SJ, Reinitz ER, Petro G, Schwartz RA, Szmalc FS. Cyclosporine central neurotoxicity following renal transplantation: report of a case using magnetic resonance images. Transplantation 1990;49:215-216
12. Ghalie R, Fitzsimmons WE, Bennett D, Kaizer H. Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 1990;6:147-149
13. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991;8:393-401
14. Wijdicks EFM, Wiesner RH, Krom RAF. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 1995;45:1962-1964
15. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627-631
16. Jansen O, Krieger D, Krieger S, Sartor K. Cortical hyperintensity on proton density-weighted images: an MR sign of cyclopsorine-related encephalopathy. AJNR Am J Neuroradiol 1996;17:337-343
17. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500
18. Ghany AM, Tutschka PJ, McGhee RB, et al. Cyclosporine associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy. Transplantation 1991; 52:310-315
19. Schwartz, RB. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:743
20. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft vs host disease after HLA-identical marrow transplantation. Blood 1989;73:2018-2024
21. Verbeke M, Van de Voorde J, de Ridder L, Lameire N. Functional analysis of vascular disfunction in cyclosporine treated rats. Cardiovasc Res 1994;28:1152-1156
22. Remuzzi G, Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 1989;13:261-272
23. Bunchman TE, Brookshire CA. Cyclosporine induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991; 88:310-314
24. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporine-induced endothelial cell injury. Lab Invest 1986;55: 455-462
25. De Groen P, Aksamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. N Engl J Med 1987;317:861-866
26. Joss DV, Barrett AJ, Rendra JR, Lucas CF, Desai S. Hypertension and convulsions in children receiving cyclosporine A. Lancet 1982; 1:906
27. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclopsorine neurotoxicity and hypomagnesemia. Lancet 1984;2:1116-1120
28. June CH, Thompson CB, Kennedy MS, Loughran TP Jr, Deeg HJ. Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients. Transplantation 1986;41:47-51
29. Nordal KP, Talseth T, Dahl E, et al. Aluminum overload, a pre-disposing condition for epileptic seizures in renal transplant patients treated with cyclosporine? Lancet 1985;2:153-154
30. Sanders TG, Clayman DA, Sanchez-Ramos L, Vines FS, Russo L Brain in eclampsia: MR imaging with clinical correlation. Radiology 1991;180:475-478
31. Vaughn DJ, Jarvik JG, Hackney D, Peters S, Stadtmauer EA. High dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993;14:1014-1016
32. Heran F, Defer G, Brugieres P, Brenot F, Gaston A, Degos JD. Cortical blindness during chemotherapy: clinical, CT, and MR correlations. J Comput Assist Tomogr 1990;14:262-266
33. Weingarten K, Barbut D, Filipi C, Zimmerman RD. Acute hypertensive encephalopathy: findings on spin-echo and gradient echo MR imaging. AJR Am J Roentgenol 1994;162;665-670
34. Edvinsson L, Owman C, Sjoberg N-O. Autonomic nerves, mast cells, and amine receptors in human brain vessels: histochemical and pharmacologic study. Brain Res 1976;115:377-393
35. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-699
36. Schriber JR, Herzig GP. Transplantation-associated thrombocytic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997;34:126-133
37. Spruce WE, Forman SJ, Blume KG, et al. Hemolytic uremic syndrome after bone marrow transplantation. Acta Haematol 1982;67: 206-210
38. Johnson PRE, Liu Yin JA, Drayson MT. Thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;7:321-322
39. Juckett M, Perry EH, Daniels BS, Weisdorf DJ. Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991;7:405-409
40. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994;14:495-504
41. Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247-253
42. Kahls P, Brugger S, Schwarzinger I, et al. Microangiopathy following allogeneic bone marrow transplantation. Transplantation 1995; 60:949-957
43. Sawada H, Udaka F, Seriu N, Shindou K, Kameyama M, Tsujimura M. MRI demonstration of cortical laminar necrosis and delayed white matter injury in anoxic encephalopathy. Neuroradiology 1990; 32:319-321
44. Takahashi S, Higano S, Ishii K, et al. Hypoxic brain damage: cortical laminar necrosis and delayed changes in white matter at sequential MR imaging. Radiology 1993;189:449-456
45. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379-383